Stryker’s orthopedic sales rise 8.5% in Q2: 6 notes

Stryker saw an 8.5% year-over-year increase in net sales during the second quarter of 2024, according to financial results posted July 30.

Advertisement

Six things to know:

1. Net sales were $5.4 billion. The company’s medsurg and neurotechnology segment saw $3.1 billion in sales, an 9% increase year-over-year. 

2. Orthopedic and spine sales grew 7.9% year-over-year with $2.3 billion in sales.

3. Hip sales were $428 million, a 8.9% increase year-over-year. Knee sales were $602 million, a 7.1% increase year-over-year.

4. Trauma and extremity sales were $832 million, a 8.6% increase year-over-year.

5. Spine sales were $307 million, a 3.8% increase year-over-year.

6. Stryker’s net earnings of $825 million represent an 11.8% increase from the same time in 2023.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.